[1]陈 冉,王维伊,杨翊柠.基于TCGA 数据库分析乳腺癌组织RBP7 mRNA 表达与肿瘤免疫细胞浸润及预后的相关性[J].现代检验医学杂志,2024,39(02):75-80+180.[doi:10.3969/j.issn.1671-7414.2024.02.014]
　CHEN Ran,WANG Weiyi,YANG Yining.Correlation of RBP7 mRNA Expression in Breast Cancer Tissues with Tumor Immune Cell Infiltration and Prognosis Based on TCGA Database[J].Journal of Modern Laboratory Medicine,2024,39(02):75-80+180.[doi:10.3969/j.issn.1671-7414.2024.02.014]
点击复制

基于TCGA 数据库分析乳腺癌组织RBP7 mRNA 表达与肿瘤免疫细胞浸润及预后的相关性()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第39卷
期数:
2024年02期
页码:
75-80+180
栏目:
论著
出版日期:
2024-03-15

文章信息/Info

Title:
Correlation of RBP7 mRNA Expression in Breast Cancer Tissues with Tumor Immune Cell Infiltration and Prognosis Based on TCGA Database
文章编号:
1671-7414（2024）02-075-07
作者:
陈 冉; 王维伊; 杨翊柠
（江苏省肿瘤医院，江苏省肿瘤防治研究所，南京医科大学附属肿瘤医院检验科，南京210009）
Author(s):
CHEN Ran;  WANG Weiyi;  YANG Yining
（Department of Clinical Laboratory, Jiangsu Cancer Hospital，Jiangsu Institute of Cancer Research，the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China）
关键词:
乳腺癌; 癌症基因组图谱; 视黄醇结合蛋白7; 肿瘤浸润免疫细胞
分类号:
R737.9；R730.43
DOI:
10.3969/j.issn.1671-7414.2024.02.014
文献标志码:
A
摘要:
目的　通过生物信息学的方法探讨视黄醇结合蛋白7（retinol binding protein 7，RBP7）在乳腺癌中的作用。方法　使用R 语言基于癌症基因组图谱（the cancer genome atlas，TCGA）数据库和人类蛋白质图谱（the human protein atlas，HPA）数据库探索基因RBP7 在乳腺癌组织中的差异表达。通过Kaplan-Meier 生存分析和受试者工作特征（receiveroperating characteristic，ROC）曲线，评估RBP7 与乳腺癌临床数据的关系。基于TCGA 数据库分析RBP7 高低表达分组与不同肿瘤浸润免疫细胞（tumor-infiltrating immune cells，TIICs）的相关性。基因组富集分析（gene set enrichmentanalysis，GSEA）评估RBP7 在与表型相关度排序的基因表中的分布趋势。结果　与癌旁组织相比，乳腺癌中RBP7mRNA 表达水平下调，该分子表达在细胞核中。ROC 曲线分析显示RBP7 诊断乳腺癌的曲线下面积（area under curve，AUC）是0.943（95% CI：0.926 ～ 0.960），RBP7 的最佳截断值是6.29，敏感度和特异度分别为82.32%，93.69%。Kaplan-Meier 生存分析显示RBP7 低表达与乳腺癌患者的总生存率相关（HR=0.68，95% CI：0.49 ～ 0.93，P=0.017），RBP7 是乳腺癌发生的独立危险因素。Spearman 相关性揭示RBP7 与乳腺癌中pDC 细胞和NK 细胞呈正相关（r=0.290，0.253，均P<0.05），与Th2 细胞呈负相关(r=-0.217，P<0.05)。GSEA 表明RBP7 富集在脂肪生成、核糖体、肽配体结合受体、钙信号途径等通路中（均P <0.001）。结论　RBP7 影响乳腺癌的发生发展，可能成为乳腺癌潜在生物标志物和治疗靶点。
Abstract:
Objective　To explore the role of retinol binding protein 7 (RBP7) in breast cancer by bioinformatics. Methods　R sofrware was used to explore the differential expression of the RBP7 gene in breast cancer by the cancer genome atlas (TCGA) dataset and the human protein atlas (HPA). Relationship between RBP7 and clinical data of breast cancer was evaluated by Kaplan-Meier survival analysis and receiver operating characteristic (ROC) curves. Correlation between high and low RBP7 expression groups and different tumor-infiltrating immune cells (TIICs) were analyzed based on the TCGA database. Gene set enrichment analysis (GSEA) was used to assess the distribute trends of RBP7 in gene tables sorted by phenotypic relatedness. Results　RBP7 mRNA expression levels were down-regulated in breast cancer compared to paracancerous tissues, which were expressed in the nucleus. ROC curve analysis showed that the area under curve (AUC) of RBP7 for the diagnosis of breast cancer was 0.943 (95% CI: 0.926 ～ 0.960), and the best cut-off value of RBP7 was 6.29, with a sensitivity and specificity of 82.32% and 93.69%, respectively. Kaplan-Meier survival analysis showed that low expression of RBP7 was associated with overall survival rate in breast cancer patients (HR=0.68, 95% CI: 0.49 ～ 0.93, P=0.017), indicating that RBP7 was an independent risk factor for breast cancer. Spearman correlation showed that RBP7 was positively associated with pDC cells and NK cells (r=0.290, 0.253, all P<0.05), and negatively associated with Th2 cells (r=-0.217, P<0.05) in breast cancer. GSEA showed that RBP7 was enriched in pathways such as adipogenesis, ribosome, peptiden ligand binding receptors, and calcium signaling pathway (all P<0.001). Conclusion　RBP7 affects the occurrence and development of breast cancer, which may be a potential biomarker and therapeutic target for breast cancer.

参考文献/References:

[1] 李宜臻, 郑怡, 邓玉皎, 等. 1990~2019 年中国女性乳腺癌疾病负担及危险因素研究[J]. 中国循证医学杂志, 2021, 21(8)：876-881. LI Yizhen, ZHENG Yi, DENG Yujiao, et al. Disease burden and attributable risk factors of breast cancer in Chinese females from 1990 to 2019[J]. Chinese Journal of Evidence-based Medicine, 2021, 21(8): 876-881.
[2] 邱海波, 曹素梅, 徐瑞华. 基于2020 年全球流行病学数据分析中国癌症发病率、死亡率和负担的时间趋势及与美国和英国数据的比较[J]. 癌症, 2022,41(4)：165-177. QIU Haibo, CAO Sumei, XU Ruihua. Temporal trends in Chinese cancer incidence, mortality and burden and comparison with US and UK data based on 2020 global epidemiological data[J]. Chinese Journal of Cancer,2022, 41(4): 165-177.
[3] 张雪, 董晓平, 管雅喆, 等. 女性乳腺癌流行病学趋势及危险因素研究进展[J]. 肿瘤防治研究, 2021,48(1)：87-92. ZHANG Xue, DONG Xiaoping, GUAN Yazhe, et al. Research progress on epidemiological trend and risk factors of female breast cancer[J]. Cancer Research on Prevention and Treatment, 2021, 48(1): 87-92.
[4] ELMASRY M, BRANDL L, ENGEL J, et al. RBP7 is a clinically prognostic biomarker and linked to tumor invasion and EMT in colon cancer[J]. Journal of Cancer, 2019, 10(20): 4883-4891.
[5] KIM D H, AHN J, SUH Y, et al. Retinol binding protein 7 promotes adipogenesis in vitro and regulates expression of genes involved in retinol metabolism[J].Frontiers in Cell and Developmental Biology, 2022, 10:876031.
[6] YAN Xiaolu, GAO Zhe, ZHANG Lixia, et al. Reduced expression of RBP7 is associated with resistance to tamoxifen in luminal a breast cancer[J]. Anti-cancer Agents in Medicinal Chemistry, 2023, 23(8): 929-937.
[7] LI Huanxiang, WANG Shuqi, LIAN Zhengxing, et al. Relationship between tumor infiltrating immune cells and tumor metastasis and its prognostic value in cancer[J]. Cells, 2022, 12(1): 64.
[8] BLUM A, WANG P, ZENKLUSEN J C. SnapShot:TCGA-analyzed tumors[J]. Cell, 2018, 173(2): 530.
[9] 肖姗姗, 李越, 周艳阳, 等. 基于TCGA 数据库构建三阴性乳腺癌预后相关的ceRNA 调控网络及分析[J]. 现代检验医学杂志, 2023, 38(01): 83-88, 106. XIAO Shanshan, LI Yue, ZHOU Yanyang, et al. Construction and analysis of ceRNA regulatory network related to prognosis of triple negative breast cancer based on TCGA database[J]. Journal of Modern Laboratory Medicine, 2023, 38(01): 83-88, 106.
[10] DAI Yifei, QIANG Weijie, LIN Kequan, et al. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma[J]. Cancer Immunology, Immunotherapy:CII, 2021, 70(4): 967-979.
[11] ZHUANG Weiwei, SUN Hongwei, ZHANG Shanshan,et al. An immunogenomic signature for molecular classification in hepatocellular carcinoma[J]. Molecular Therapy Nucleic Acids, 2021, 25: 105-115.
[12] REIMAND J, ISSERLIN R, VOISIN V, et al. Pathway enrichment analysis and visualization of omics data using g: Profiler, GSEA, Cytoscape and EnrichmentMap[J].Nature Protocols, 2019, 14(2): 482-517.
[13] HUANG Xingxing, KE Kun, JIN Weiwei, et al. Identification of genes related to 5-fluorouracil based chemotherapy for colorectal cancer[J]. Frontiers in Immunology, 2022, 13:887048.
[14] JIN Kun, QIU Shi, JIN Di, et al. Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database[J]. Aging, 2021, 13(2): 1859-1871.
[15] LIU Yifan, FAN Mingxiang, XIAN Shuyuan, et al. RBP7 regulated by EBF1 affects Th2 cells and the oocyte meiosis pathway in bone metastases of bladder urothelial carcinoma[J]. Frontiers in Bioscience (Landmark Edition), 2023, 28(8): 189.
[16] 孙飞, 黎春明. 基于免疫细胞组织浸润的免疫评分模型预测前列腺癌免疫治疗效果及预后分析研究[J]. 现代检验医学杂志, 2023, 38(3)：189-194. SUN Fei, LI Chunming. Prediction of immunotherapy effect and prognosis of prostate cancer based on immune cell tissue infiltration immune score model[J].Journal of Modern Laboratory Medicine, 2023, 38(3):189-194.
[17] WANG Shiyuan, XIONG Yuqiang, ZHANG Qi, et al. Clinical significance and immunogenomic landscape analyses of the immune cell signature based prognostic model for patients with breast cancer[J]. Briefings in Bioinformatics, 2021, 22(4): bbaa311.
[18] BOIERI M, MALISHKEVICH A, GUENNOUN R,et al. CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation[J]. Journal of Experimental Medicine, 2022, 219(7): e20201963.
[19] 钟恋君, 王进京, 郑洪. 三阴型乳腺癌间质肿瘤浸润淋巴细胞CD4, CD8, Foxp3 和PD-L1 表达的临床病理意义[J]. 临床与实验病理学杂志, 2022, 38(3)：278-283, 288. ZHONG Lianjun, WANG Jinjing, ZHENG Hong. Clinicopathological significance for the expression of CD4,CD8,Foxp3 and PD?L1 of stromal tumor?infiltrating lymphocytes in triple negative breast cancer[J]. Chinese Journal of Clinical and Experimental Pathology, 2022, 38(3): 278-283, 288.
[20] 李玥婷, 施鹏旭, 英子伟, 等. 自然杀伤细胞,CD19+对乳腺癌患者保乳手术治疗后复发预测价值研究[J]. 临床军医杂志, 2019, 47(03)：250-252. LI Yueting, SHI Pengxu, YING Ziwei, et al. The predictive value of natural killer cells and CD19+ in breast cancer patients after breast conserving surgery[J]. Clinical Journal of Medical Officers, 2019, 47(03): 250-252.
[21] ISHAY-RONEN D, DIEPENBRUCK M, KALATHUR R K R, et al. Gain Fat-lose metastasis: converting invasive breast cancer cells into adipocytes inhibits cancer metastasis[J]. Cancer Cell, 2019, 35(1): 17-32.e6.
[22] LI Xinyan, WANG Mengshen, LI Su, et al. HIF-1-induced mitochondrial ribosome protein L52: a mechanism for breast cancer cellular adaptation and metastatic initiation in response to hypoxia[J].Theranostics, 2021, 11(15): 7337-7359.

相似文献/References:

[1]党小军,张华,王欣.人附睾蛋白4(HE4)在乳腺癌诊断中的价值[J].现代检验医学杂志,2015,30(06):84.[doi:10.3969/j.issn.1671-7414.2015.06.024]
　DANG Xiao-jun,ZHANG Hua,WANG Xin.Value of Human Epididymis Protein 4(HE4) in Diagnosis of Breast Cancer[J].Journal of Modern Laboratory Medicine,2015,30(02):84.[doi:10.3969/j.issn.1671-7414.2015.06.024]
[2]张 萍,任世云,张 雷.乳腺癌患者血清脂质运载蛋白-2 和基质金属蛋白酶-9的表达及临床意义[J].现代检验医学杂志,2015,30(01):72.[doi:10.3969/j.issn.1671-7414.2015.01.019]
　ZHANG Ping,REN Shi-yun,ZHANG Lei.Expression and Clinical Significance of Serum LCN-2 and MMP-9 in Patients with Breast Cancer[J].Journal of Modern Laboratory Medicine,2015,30(02):72.[doi:10.3969/j.issn.1671-7414.2015.01.019]
[3]乔雪峰a,黄志平b,张 宁c,等.IL-18基因启动子区-137G/C,-607G/T 2个位点基因多态性与女性乳腺癌易感性Meta分析[J].现代检验医学杂志,2016,31(04):65.[doi:10.3969/j.issn.16717-414.2016.04.017]
　QIAO Xue-fenga,HUANG Zhi-pingb,ZHANG Ningc,et al.Association Analysis of IL-18 Gene Promoter Region -137G/C,-607G/T Polymorphisms and Susceptibility to Sporadic Breast Cancer:Meta-Analysis[J].Journal of Modern Laboratory Medicine,2016,31(02):65.[doi:10.3969/j.issn.16717-414.2016.04.017]
[4]刘延梅,马少君,张月浪,等.人类表皮生长因子受体2在乳腺癌表达与临床的相关病理特征分析[J].现代检验医学杂志,2016,31(05):91.[doi:10.3969/j.issn.1671-7414.2016.05.024]
　LIU Yan-mei,MA Shao-jun,ZHANG Yue-lang,et al.Expression of Human Epidermal Growth Factor Receptor 2 and Correlation with Clinical Pathological Features in Breast Cancer[J].Journal of Modern Laboratory Medicine,2016,31(02):91.[doi:10.3969/j.issn.1671-7414.2016.05.024]
[5]陈雨欣,谭婷婷,宁明哲.乳腺癌患者血清中白介素35(IL-35)的表达及其临床意义[J].现代检验医学杂志,2017,32(02):92.[doi:10.3969/j.issn.1671-7414.2017.02.025]
　CHEN Yu-xin,TAN Ting-ting,NING Ming-zhe.Serological Interleukin-35 Level in Patients with Breast Cancer and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2017,32(02):92.[doi:10.3969/j.issn.1671-7414.2017.02.025]
[6]唐努尔·艾尔肯,阿孜古·祖农.盐酸罗哌卡因对人乳腺癌细胞运动作用的研究[J].现代检验医学杂志,2017,32(03):128.[doi:10.3969/j.issn.1671-7414.2017.03.035]
　TANGNUER·Aierken,AZIGU·Zunong.Study on Effect of Ropivacaine on Migration of Breast Cancer Cell s[J].Journal of Modern Laboratory Medicine,2017,32(02):128.[doi:10.3969/j.issn.1671-7414.2017.03.035]
[7]靳庆娥,苏建荣.北京地区汉族女性人群SYK基因启动子区-803A>Trs290987单核苷酸多态性与乳腺癌易感性分析[J].现代检验医学杂志,2018,33(02):5.[doi:10.3969/j.issn.1671-7414.2018.02.001]
　JIN Qing-e,SU Jian-rong.Associations of SYK Promoter-803A >T(rs290987)Single Nucleotide Polymorphisms with Susceptibility to Breast Cancer of Han Female Population in Beijing Area[J].Journal of Modern Laboratory Medicine,2018,33(02):5.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[8]高 华a,李玉柱b,韩龙才c,等.Logistic回归和ROC工作曲线评价联合检测血清CA153,TPS,CYFRA21-1在乳腺癌诊断中的临床价值[J].现代检验医学杂志,2018,33(03):60.[doi:10.3969/j.issn.1671-7414.2018.03.016]
　GAO Huaa,LI Yu-zhub,HAN Long-caic,et al.Clinical Value of Logistic Regression and ROC Work Curve Evaluating Serum CA153,TPS and Cyfra21-1 for Diagnosis of Breast Cancer[J].Journal of Modern Laboratory Medicine,2018,33(02):60.[doi:10.3969/j.issn.1671-7414.2018.03.016]
[9]李 娜a,赵晓娟b,苏晓明a.乳腺组织中SMG-1mRNA和SOX4mRNA检测在乳腺癌监测中的应用[J].现代检验医学杂志,2019,34(02):35.[doi:10.3969/j.issn.1671-7414.2019.02.010]
　LI Naa,ZHAO Xiao-juanb,SU Xiao-minga.Application of Detection of SMG-1mRNA and SOX4mRNAin Breast Tissue in Surveillance for Breast Cancer[J].Journal of Modern Laboratory Medicine,2019,34(02):35.[doi:10.3969/j.issn.1671-7414.2019.02.010]
[10]王 碧,吉茂礼.乳腺癌组织长链非编码RNA UCA1和BCAR4表达与辅助化疗效果的相关性研究[J].现代检验医学杂志,2019,34(05):77.[doi:10.3969/j.issn.1671-7414.2019.05.019]
　WANG Bi,JI Mao-li.Correlational Research on the Expressionof Long-Chain Non-Coding RNA UCA1 and BCAR4in Breast Cancer Tissues for the Effect of Adjuvant Chemotherapy[J].Journal of Modern Laboratory Medicine,2019,34(02):77.[doi:10.3969/j.issn.1671-7414.2019.05.019]

备注/Memo

备注/Memo:
基金项目： 江苏省卫生健康委科研项目（M2022106）：tRF-17-79MP9PP 作为miR-18a-5p 分子海绵调控THBS1/TGF-β1/Smad3 信号轴介导乳腺癌发生发展的机制研究。
作者简介：陈冉(1986-)，女，本科，主管技师，主要从事临床检验诊断学相关研究，E-mail: 28692095@qq.com。
通讯作者：杨翊柠(1988-)，女，硕士，主管技师，主要从事临床检验诊断学相关研究，E-mail:neko4713@live.cn。
更新日期/Last Update: 2024-03-15